Literature DB >> 10626103

Preoperative and postoperative considerations for carbon dioxide laser resurfacing.

S Horton1, T S Alster.   

Abstract

Cutaneous laser resurfacing is a tremendous advance in the treatment of photoaged skin. With the recent developments in laser technology, the procedure has become widely utilized among many physician subspecialists. The latest laser systems permit controlled vaporization of skin so that most novice operators feel comfortable with the technique in a short period of time. Nevertheless, there are many issues that need to be addressed before performing the procedure. First, not every person is an appropriate candidate for laser resurfacing. Second, both the physician and the patient must be aware of the preoperative preparation and prolonged postoperative care involved with the procedure. Finally, the physician must be able to identify and treat, and the patient must be educated about, the side effects and potential complications associated with the procedure. It is only by addressing these issues that the clinical results obtained by CO2 laser resurfacing can be maximized.

Entities:  

Mesh:

Year:  1999        PMID: 10626103

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  3 in total

1.  Random fractional ultrapulsed CO2 resurfacing of photodamaged facial skin: long-term evaluation.

Authors:  Matteo Tretti Clementoni; Michela Galimberti; Athanasia Tourlaki; Maximilian Catenacci; Rosalia Lavagno; Pier Luca Bencini
Journal:  Lasers Med Sci       Date:  2012-05-24       Impact factor: 3.161

2.  A Pilot Study of Skin Resurfacing Using the 2,790-nm Erbium:YSGG Laser System.

Authors:  Jong Won Rhie; Jeong Su Shim; Won Seok Choi
Journal:  Arch Plast Surg       Date:  2015-01-14

3.  Image analysis and processing methods in verifying the correctness of performing low-invasive esthetic medical procedures.

Authors:  Robert Koprowski; Slawomir Wilczyński; Arkadiusz Samojedny; Zygmunt Wróbel; Anna Deda
Journal:  Biomed Eng Online       Date:  2013-06-09       Impact factor: 2.819

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.